Welcome to Medpoint, LLC, a leading domestic and international consulting firm for Quality Assurance, Regulatory and Clinical Affairs. We have over 100 of the most highly qualified consultants working all levels of projects in Medical Device, Biotech, and Pharmaceutical in over 90 countries.
Our clients span the spectrum from start-up to Fortune 20 and look to us for short-term or long-term expertise in the following areas:
As I do my best to keep my finger on the pulse of the industry and market, here’s my assessment. I think a lot of the companies are holding on to the cash knowing there are pending FDA issues. Some of these issues have been exposed, others are known but not exposed yet. It’s a [...]
Continue reading »IR-2010-25, March 2, 2010
WASHINGTON — The Internal Revenue Service has made an administrative determination to accept the position that medical residents are excepted from FICA taxes based on the student exception for tax periods ending before April 1, 2005, when new IRS regulations went into effect.
The IRS will, within 90 days, begin contacting hospitals, universities [...]
By Thomas Lee
Image via Wikipedia
MINNEAPOLIS, Minnesota — “We’re not here to bash the FDA,” Mark DuVal, president of Minneapolis law firm DuVal & Associates, told a group of medical device executives and investors late Wednesday afternoon.
Too late.
The newly formed Minnesota Medical Device Alliance billed the gathering in the downtown Warehouse District as the first step [...]
By ALICIA MUNDY And JARED A. FAVOLE
WASHINGTON—The Food and Drug Administration may tighten or eliminate several pathways for getting a medical device approved quickly amid concerns they have been overused by industry, according to an internal agency memo reviewed by The Wall Street Journal.
The proposals came in a Dec. 22 briefing involving officials in the [...]
Boston Scientific Corp. (NYSE:BSX) will pay Johnson & Johnson (NYSE:JNJ) $1.725 billion to settle a quartet of patent infringement lawsuits concerning the companies’ lines of cardiovascular stents.
The Natick, Mass.-based medical devices monolith agreed to the settlement, which calls for it to pay J&J $1 billion today and the rest in about a year, said it [...]
